Kardalas Efstratios, Paikopoulou Aggeliki, Vassiliadi Dimitra A, Kounatidis Dimitris, Vallianou Natalia G, Vourlakou Christine, Karampela Irene, Dalamaga Maria, Tzanela Marinella, Stratigou Theodora
Department of Endocrinology, Diabetes and Metabolism, European and National Expertise Center for Rare Endocrine Disorders, Evangelismos General Hospital, 10676, Athens, Greece.
Department of Nephrology, Evangelismos General Hospital, 45-47 Ipsilantou Str., 10676, Athens, Greece.
Metabol Open. 2024 Aug 28;23:100313. doi: 10.1016/j.metop.2024.100313. eCollection 2024 Sep.
Diabetes mellitus (DM) is tightly associated with the increased prevalence of diabetic kidney disease (DKD). Nonetheless, severe renal function impairment and/or nephrotic range-proteinuria could also result from non-diabetic renal disease (non-DRD) among patients with DM. The 'Gold standard' for the differential diagnosis between DKD and non-DRD is kidney biopsy, although no real consensus exists. Thus, this study intends to associate the clinical and biochemical profile of patients with DM and renal disease with the histopathological data of kidney biopsy.In addition, we aimed to evaluate the role of kidney biopsy, especially when other causes, other than DM, are highly suspected among patients with DM and kidney disease.
Thirty two patients with T2DM and nephrotic range levels of proteinuria or with co-existing factors pointing towards a non-diabetic origin of kidney disease were studied, retrospectively. All 32 patients underwent kidney biopsy and were classified according to histopathological findings into 3 groups: a) isolated diabetic kidney disease (DKD), b) non-diabetic kidney disease (NDKD) and c) mixed kidney disease (MKD).
Fifteen out of the 32 patients had findings of an isolated DKD, while 17 out of 32 patients suffered from NDKD (13 patients) or MKD (4 patients). DKD patients were younger (p = 0.016) and had a higher HbA1c value (p = 0.069, borderline statistical significance), while the NDKD patients had significantly shorter disease duration (p = 0.04). Furthermore, the incidence of diabetic retinopathy (DR) was lower among the NDKD patients (p < 0.001), who had also significantly less interstitial fibrosis (p = 0.02). Finally, the presence of DR, higher levels of interstitial fibrosis and longer T2DM duration were recognized as factors, which were positively associated with DKD.
This study advocates the usefulness of kidney biopsy in patients with T2DM and nephrotic range levels of proteinuria, especially when DR is absent and shorter disease duration is observed.
糖尿病(DM)与糖尿病肾病(DKD)患病率的增加密切相关。然而,糖尿病患者中的非糖尿病性肾病(non-DRD)也可能导致严重的肾功能损害和/或肾病范围蛋白尿。尽管目前尚无真正的共识,但肾活检仍是DKD与non-DRD鉴别诊断的“金标准”。因此,本研究旨在将糖尿病肾病患者的临床和生化特征与肾活检的组织病理学数据相关联。此外,我们旨在评估肾活检的作用,特别是在糖尿病肾病患者中高度怀疑存在糖尿病以外的其他病因时。
回顾性研究了32例2型糖尿病患者,这些患者有肾病范围的蛋白尿水平或存在提示肾病非糖尿病起源的共存因素。所有32例患者均接受了肾活检,并根据组织病理学结果分为3组:a)单纯糖尿病肾病(DKD),b)非糖尿病肾病(NDKD),c)混合性肾病(MKD)。
32例患者中有15例表现为单纯DKD,而32例患者中有17例患有NDKD(13例)或MKD(4例)。DKD患者更年轻(p = 0.016),糖化血红蛋白值更高(p = 0.069,具有临界统计学意义),而NDKD患者的病程明显更短(p = 0.04)。此外,NDKD患者的糖尿病视网膜病变(DR)发生率较低(p < 0.001),其间质纤维化也明显较少(p = 0.02)。最后,DR的存在、较高水平的间质纤维化和较长的2型糖尿病病程被认为是与DKD呈正相关的因素。
本研究提倡对2型糖尿病和肾病范围蛋白尿水平的患者进行肾活检,特别是在无DR且病程较短的情况下。